Dr. Benjamin Weinberg, MD

Dr. Benjamin Weinberg, MD

Dr. Benjamin Weinberg, MD

Languages: English

Contact this Provider:

Specialties
  • Medical Oncology
Conditions I Treat
  • anal cancer
  • carcinoid tumor
  • cholangiocarcinoma
  • colorectal malignancy
  • esophageal cancer
  • Show All
About the Provider

Dr. Weinberg is an Assistant Professor of Medicine and Attending Physician specializing in gastrointestinal medical oncology and sarcoma. Dr. Weinberg is focused on developing new therapies for colorectal and pancreatic cancers by translating research from animal models into early phase clinical trials in humans. He also studies young patients with colorectal cancer in order to understand the dramatic rise in incidence of left-sided colon and rectal cancers in this population.

Dr. Weinberg obtained his undergraduate degree in biomedical science at the University of Pennsylvania in 2007 and his MD at the Keck School of Medicine of the University of Southern California in 2011. He completed his post-graduate medical training at MedStar Georgetown University Hospital with a residency in internal medicine in 2014 and a fellowship in hematology and oncology in 2017 where he served as the Chief Fellow from 2016 to 2017.

Throughout his medical career, Dr. Weinberg has worked exhaustively to make sure that patients are heard and that they receive the highest quality of care. His training as a resident and fellow at Georgetown leads him in the pursuit of cura personalis (“care for the whole person”), and he brings this mindset every day into the clinic and all his work with patients.

Education
  • Fellowship Program: MedStar Georgetown University Hospital (2017)
  • Internship/Residency: MedStar Georgetown University Hospital (2014)
  • Medical School: Keck School of Medicine of the University of Southern California (2011)
  • Board Certification: American Board of Internal Medicine, Medical Oncology
  • Board Certification: American Board of Internal Medicine, Hematology
  • Board Certification: American Board of Internal Medicine, Internal Medicine
Publications
  • Salem ME*, Weinberg BA*, Xiu J, El-Deiry WS, Hwang JJ, Gatalica Z, Philip PA, Shields AF, Lenz HJ, Marshall JL. (2017) Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers. Oncotarget, 8(49):86356-86368. *Co-first authors.
  • Puthiamadathil JM, Weinberg BA. (2017) Emerging combination therapies for metastatic colorectal cancer – impact of trifluridine/tipiracil. Cancer Management and Research, 2017(9):461-469.
  • Serzan MT, Weinberg BA, Salem ME. (2017) Second-line therapy in advanced colorectal cancer: EGFR vs. continuation of VEGF inhibition. Current Colorectal Cancer Reports.
  • Weinberg BA, Hartley M, Salem ME. (2017) Precision medicine in metastatic colorectal cancer: relevant carcinogenic pathways and targets. Part 1: biologic therapy targeting epidermal growth factor receptor and vascular endothelial growth factor. Oncology (Williston Park), 31(7):539-548.
  • Weinberg BA, Hartley M, Salem ME. (2017) Precision medicine in metastatic colorectal cancer: relevant carcinogenic pathways and targets. Part 2: approaches beyond first-line therapy, and novel biologic agents under investigation. Oncology (Williston Park), 31(7):573-580.
  • Weinberg BA, Marshall JL, Salem ME. (2017) The growing challenge of young adults with colorectal cancer. Oncology (Williston Park), 31(5):381-389.
  • Weinberg BA, Philip PA, Salem ME. (2017) Evolving standards of care for resected pancreatic cancer. Clinical Advances in Hematology & Oncology, 15(2):141-150.
  • Weinberg BA, Gowen K, Lee TK, Ou SH, Bristow R, Krill L, Almira-Suarez MI, Ali SM, Miller VA, Liu SV, Klempner SJ. (2017) Comprehensive genomic profiling aids in distinguishing metastatic recurrence from second primary cancers.The Oncologist, 22(2):152-157.
  • Weinberg BA, Marshall JL, Salem ME. (2016) Trifluridine/tipiracil and regorafenib: new weapons in the war against metastatic colorectal cancer. Clinical Advances in Hematology & Oncology, 14(8):630-638.
  • Weinberg BA, Marshall JL, Hartley M, Salem ME. (2016) A paradigm shift from one-size-fits-all to tailor-made therapy for metastatic colorectal cancer. Clinical Advances in Hematology & Oncology, 14(2):116-128.
  • Weinberg BA, Yabar CS, Brody JR, Pishvaian MJ. (2015) Current standards and novel treatment options for metastatic pancreatic adenocarcinoma. Oncology (Williston Park), 29(11):809-820, 886.
  • Weinberg BA, Wang H, Yang X, Wu CS, Pishvaian MJ, He AR, Marshall JL, Hwang JJ. (2014) Maintenance therapy with capecitabine in patients with resected pancreatic adenocarcinoma after adjuvant therapy, a retrospective cohort study. Gastrointestinal Cancer Research, 7(3-4):91-97.
  • El-Chemaly S, Malide D, Zudaire E, Ikeda Y, Weinberg BA, Pacheco-Rodriguez G, Rosas IO, Aparicio M, Ren P, MacDonald SD, Wu HP, Nathan SD, Cuttitta F, McCoy JP, Gochuico BR, Moss J. (2009) Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms. Proceedings of the National Academy of Sciences of the United States of America, 106(10):3958-3963.
Insurance
Practice Locations
Member of Medical Staff
  • MedStar Georgetown University Hospital
Awards
  • First Place, Fellow Clinical Research Award, Georgetown Department of Medicine Research Day
  • 2017 Conquer Cancer Foundation Gastrointestinal Cancers Symposium Merit Award
  • 2016 Conquer Cancer Foundation of ASCO Young Investigator Award
  • AACR/ASCO Workshop on Methods in Clinical Cancer Research Invited Participant, Vail, CO
  • Donald E. and Delia B. Baxter Foundation Award
  • Medical Student Summer Research Fellowship, Keck School of Medicine
  • Dean’s Recognition, Keck School of Medicine of the University of Southern California
  • NIH Summer Intramural Research Training Award Fellowships